The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of an alpha-lactalbumin vaccine in patients with moderate- to high-risk operable triple-negative breast cancer (TNBC).
 
George Thomas Budd
Honoraria - Deciphera
Consulting or Advisory Role - Epic Sciences; GRAIL; Partnership for Health Analytic Research, LLC
Speakers' Bureau - Deciphera
Research Funding - Ambrx (Inst); Ayala Pharmaceuticals (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo/Lilly (Inst); Genentech/Roche (Inst); Salarius Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Justin M. Johnson
Patents, Royalties, Other Intellectual Property - I am named on patents that pertain to breast cancer and ovarian cancer vaccine technology
Other Relationship - Anixa Biosciences; Anixa Biosciences (Inst)
 
Emily Esakov Rhoades
No Relationships to Disclose
 
Halle C. F. Moore
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Roche (Inst); Sermonix Pharmaceuticals (Inst)
 
Megan Lynn Kruse
Consulting or Advisory Role - Eisai; Immunomedics; Lilly; Novartis; Puma Biotechnology; Seagen
Research Funding - Tempus
 
Erin Elizabeth Roesch
No Relationships to Disclose
 
Jame Abraham
Research Funding - Daiichi Sankyo/Astra Zeneca (Inst); Pfizer (Inst); Seagen (Inst)
 
Brenna Elliott
No Relationships to Disclose
 
Donna Lach
No Relationships to Disclose
 
Vincent K. Tuohy
Stock and Other Ownership Interests - Anixa Biosciences
Research Funding - Anixa Biosciences
Patents, Royalties, Other Intellectual Property - Anixa Biosciences